semaglutide for obesity walnut creek receives FDA approval Weight Loss Weight loss drug semaglutide reduces

This is particularly true in vulnerable populations such as women and obese patients. Although GLP-1 receptor agonists have been approved for obesity and diabetes, Xavier said, their role in smoking cessation remains unclear, prompting her and her colleagues to conduct a systematic review and meta-analysis

So far only one oral GLP-1 has appeared on the market, in 2019

GLP-1 medications qualify when prescribed for type 2 diabetes, obesity with comorbidities, or other FDA-approved indicationsnot for weight loss alone in otherwise healthy individuals

author reply -1

High prolactin levels inhibit gonadotropin release and can cause anovulation

Stucky, Semaglutide vs tirzepatide for weight loss in adults with overweight or obesity